SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010
11 references·8 citing·28 second hop
Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)Residual risk of transfusion-transmitted …Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study‐II blood centers in Brazil (2011)Human immunodeficiency virus …Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Current incidence and estimat…Hepatitis B virus blood screening: unfinished agendas (2006)Hepatitis B virus blood scree…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000 (2002)Trends in residual risk of tr…Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT (2002)Mathematic modeling of the ri…Estimated risk of transfusion‐transmitted viral infections in Spain (2002)Estimated risk of transfusion…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Assessing the accuracy of thr…Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period (2000)Failure of Routine HIV-1 Test…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Current State of Blood Management Services in Korea (2021)Current State of Blood Manage…Blood Supply and Demand in Korea: What is in Store for the Future? (2020)Blood Supply and Demand in Ko…Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Residual risk of transmission…Prevalence and trends of transfusion-transmittable infections among blood donors in Southwest China (2017)Prevalence and trends of tran…A Seven Year Review of the Seroprevalence of Transfusion Transmitted Infections in a Hospital Based Blood Bank in Ibadan, Nigeria (2017)A Seven Year Review of the Se…Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013 (2015)Prevalence and trends of tran…The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. (2014)The risk of transfusion-trans…Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives (2013)Residual Risk of Hepatitis-B-…Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests (1995)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia (2007)A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus (2008)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa (2011)Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services (2012)Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation (2018)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)False-Positive HIV-1 Test Results in a Low-Risk Screening Setting of Voluntary Blood Donation (1998)NAT and blood safety: what is the paradigm? (2000)First report of human immunodeficiency virus transmission via an RNA‐screened blood donation (2004)Window‐period human immunodeficiency virus transmission to two recipients by an adolescent blood donor (2004)10.1016/s0000-0000(03)47688-2 (2000)Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral (2004)Residual risk of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy (2005)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Prevention of transfusion-transmitted infections (2019)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Health and economic impact of posttransfusion hepatitis B and cost‐effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union (2003)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2007Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services154 cited
  • 2002Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT117 cited
  • 2000Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period108 cited
  • 2002Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 200098 cited
  • 2006Hepatitis B virus blood screening: unfinished agendas94 cited
  • 2002Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT78 cited
  • 2002Estimated risk of transfusion‐transmitted viral infections in Spain69 cited
  • 2011Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study‐II blood centers in Brazil64 cited

Cited by

  • 2014The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

43 cited
  • 2021Current State of Blood Management Services in Korea30 cited
  • 2017Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil25 cited
  • 2015Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 201321 cited
  • 2020Blood Supply and Demand in Korea: What is in Store for the Future?20 cited
  • 2017A Seven Year Review of the Seroprevalence of Transfusion Transmitted Infections in a Hospital Based Blood Bank in Ibadan, Nigeria14 cited
  • 2017Prevalence and trends of transfusion-transmittable infections among blood donors in Southwest China10 cited
  • 2013Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives7 cited